Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
Search Stories
Banking on mobile money
A cellphone-based cash transfer system has changed the way Kenyans handle their finances. But what does it mean for Kenya's economy — and the developing world?
Jack Wozencraft, information theorist at MIT, 1925-2009
Jack Wozencraft, considered one of the pioneers of coding theory in the nascent field of information theory, died peacefully August 31, 2009.
A greener way to get electricity from natural gas
A proposed system would use solid-oxide fuel cells to produce power without sending CO2 into the atmosphere. But can it compete with conventional power plants?
MIT Sport Shorts — NCAA Championship news and NEWMAC honors
Roundup of news from MIT's fall sports season
Possible origins of pancreatic cancer revealed
Tumors can arise from different cell types in the pancreas, depending on the circumstances, according to MIT cancer biologists.
Cancer research gets physical
5-year grant from the National Cancer Institute will fund projects by physicists that give a new view of cancer cells.
Protein is linked to lung cancer development
Drugs that inhibit the protein, which normally helps defend cells from infection, could target tumors in certain lung cancer patients.
Two from MIT elected to the Institute of Medicine
Professor of Economics Amy Finkelstein and Tyler Jacks, director of the Koch Institute, join arm of the National Academies of Science.
Men's basketball coach Anderson honored by New England Basketball Hall of Fame
Named New England Division III Coach of the Year
A turning point in the struggle against cancer?
Using new tools, ideas and ways of working, MIT biologists and engineers hope to change paradigm.